Difference between revisions of "Part:BBa K4175000:Design"

(→‎References)
(→‎References)
 
Line 16: Line 16:
  
 
===References===
 
===References===
−
ADRIAN, T.H.J., DARIO, C., 2021. Neutralization of Human Cytokines with Membrane-Bound Anti-Cytokine Non-Signaling Binders Expressed in Immune Cells.
+
Tan, A.H.J., Vinanica, N., Campana, D., 2020. Chimeric antigen receptor–T cells with cytokine neutralizing capacity. Blood Adv. 4, 1419–1431. https://doi.org/10.1182/bloodadvances.2019001287

Latest revision as of 08:06, 25 September 2022


anti-IL-6 scFv


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 604
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal PstI site found at 604
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 512
    Illegal XhoI site found at 496
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 604
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 604
    Illegal AgeI site found at 556
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

The sequence has been condon optimized for human.


Source

Human. Sequence found in ADRIAN, T.H.J., DARIO, C., 2021. Neutralization of Human Cytokines with Membrane-Bound Anti-Cytokine Non-Signaling Binders Expressed in Immune Cells. https://www.lens.org/lens/patent/040-383-008-445-12X/citations?view=in

References

Tan, A.H.J., Vinanica, N., Campana, D., 2020. Chimeric antigen receptor–T cells with cytokine neutralizing capacity. Blood Adv. 4, 1419–1431. https://doi.org/10.1182/bloodadvances.2019001287